ZEB1 and familial pancreatic carcinoma: The results indicated a negative effect of high ZEB-1 expression on OS (univariable analysis) in patients with colorectal cancer (pooled HR: 1.80; 95% CI: 1.28–2.54) (Fig. 4a), esophageal squamous cell carcinoma (pooled HR: 1.71; 95% CI: 1.38–2.13) (Fig. 4b) and pancreatic cancer (pooled HR: 1.63; 95% CI: 1.19–2.23) (Fig. 4c).